Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction

A Kastrati, A Dibra, C Spaulding… - European heart …, 2007 - academic.oup.com
Aims To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in
patients with acute ST-segment elevation myocardial infarction. Methods and results We …

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis

SS Brar, MB Leon, GW Stone, R Mehran… - Journal of the American …, 2009 - jacc.org
Objectives: The primary aim of the analysis was to compare outcomes by stent type for
death, myocardial infarction (MI), target vessel revascularization (TVR), and stent thrombosis …

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction

V Pasceri, G Patti, G Speciale, C Pristipino… - American heart …, 2007 - Elsevier
BACKGROUND: Recent trials have shown the effects of drug-eluting stents (DES) in
treatment of acute myocardial infarction (AMI), but data on the clinical outcome are still …

Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary …

PG Steg, KAA Fox, KA Eagle, M Furman… - European heart …, 2009 - academic.oup.com
Aims To assess mortality after drug-eluting stent (DES) or bare-metal stent (BMS) for ST-
segment elevation myocardial infarction (STEMI). Methods and results In this multinational …

Assessment of the performances of multilayer perceptron neural networks in comparison with recurrent neural networks and two statistical methods for diagnosing …

N Süt, M Şenocak - Expert Systems, 2007 - Wiley Online Library
We aimed to examine the diagnostic performances of multilayer perceptron neural networks
(MLPNNs) for predicting coronary artery disease and to compare them with different types of …

Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

A Dibra, K Tiroch, S Schulz, H Kelbæk… - Clinical research in …, 2010 - Springer
Background Use of drug-eluting stents in patients with acute myocardial infarction (AMI)
remains an “off label” indication due to concerns regarding their performance in this patient …

Percutaneous coronary intervention with stenting of left main coronary artery with drug-eluting stent in the setting of acute ST elevation myocardial infarction

CH Tan, MK Hong, CW Lee, YH Kim, CH Lee… - International journal of …, 2008 - Elsevier
AIM: Primary angioplasty of the left main coronary is not a common procedure. We present
16 cases of angioplasty of left main coronary artery with drug-eluting stent (DES) …

Clinical impact of sirolimus‐eluting stent in ST‐segment elevation myocardial infarction: a meta‐analysis of randomized clinical trials

F Piscione, R Piccolo, S Cassese… - Catheterization and …, 2009 - Wiley Online Library
Objectives: To evaluate outcome of patients undergoing sirolimus‐eluting stent (SES) as
compared to bare‐metal stent (BMS) implantation during primary angioplasty for ST …

Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents

MS Park, D Fiorella, MF Stiefel, SR Dashti… - …, 2010 - journals.lww.com
BACKGROUND: Vertebral origin angioplasty and stenting (VOAS) with bare metal stents is
associated with a high rate of in-stent restenosis (ISR). OBJECTIVE: We evaluated the rate …

Correlates of late and very late thrombosis of drug eluting stents

GJ Mishkel, AL Moore, S Markwell, ME Shelton - American Heart Journal, 2008 - Elsevier
BACKGROUND: Late and very late thrombosis of coronary drug-eluting stents (DES) has
received much attention but essentially remains unpredictable. We sought to identify …